DeepMed Research

Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy

Withdrawn

Conditions: Brain Tumors

Interventions: Procedure: fMRI Evaluation

First Posted Date: 2010-09-30

Last Posted Date: 2019-07-29

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT01212237

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

SCALE: Small Changes and Lasting Effects

Not Applicable

Completed

Conditions: Obesity
Overweight

Interventions: Behavioral: Group 1
Behavioral: Group 2

First Posted Date: 2010-09-10

Last Posted Date: 2017-02-23

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 405

Registration Number: NCT01198990

Locations: 🇺🇸
Lincoln Medical and Mental Health Center, Bronx, New York, United States
🇺🇸
Iglesia Congregacion Cristiana del Bronx, Bronx, New York, United States
🇺🇸
East Side House Settlement, Bronx, New York, United States

and more 3 locations

Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy

Completed

Conditions: Coronary Artery Disease
Ischemia

First Posted Date: 2010-08-03

Last Posted Date: 2017-05-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 31

Registration Number: NCT01174095

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
Stony Brook University Medical Center, Stony Brook, New York, United States

Collection of Blood for Gene Expression/Genomic Studies in Individuals With Diabetes (Qatar)

Terminated

Conditions: Type 2 Diabetes Mellitus
Diabetes Mellitus

First Posted Date: 2010-07-30

Last Posted Date: 2020-07-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 450

Registration Number: NCT01172743

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

Safety Study of a Gene Transfer Vector (Rh.10) for Children With Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)

Phase 1

Completed

Conditions: Batten Disease
Late-Infantile Neuronal Ceroid Lipofuscinosis

Interventions: Biological: AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies
Biological: AAVrh.10CUhCLN2 vector 2.85x10^11 genome copies

First Posted Date: 2010-07-13

Last Posted Date: 2021-02-02

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 12

Registration Number: NCT01161576

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Drug: dexamethasone
Drug: clarithromycin
Drug: Pomalidomide

First Posted Date: 2010-07-09

Last Posted Date: 2019-06-11

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 121

Registration Number: NCT01159574

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma

Phase 1

Terminated

Conditions: Follicular Lymphoma

Interventions: Drug: 90Y-epratuzumab tetraxetan
Biological: veltuzumab

First Posted Date: 2010-06-22

Last Posted Date: 2018-02-22

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 4

Registration Number: NCT01147393

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma

Phase 3

Completed

Conditions: Multiple Myeloma

Interventions: Drug: bortezomib (Velcade)
Drug: cyclophosphamide
Drug: Plerixafor
Drug: G-CSF

First Posted Date: 2010-06-22

Last Posted Date: 2019-12-27

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 47

Registration Number: NCT01146834

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center):, New York, New York, United States
🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
New York University Cancer Institute, New York, New York, United States

and more 2 locations

Assessing the Impact of Health Information Exchange (HIE) on Healthcare Utilization

Completed

Conditions: Health Care Utilization
Health Information Technology
Health Information Exchange
Virtual Health Record

Interventions: Other: Virtual Health Record (VHR)

First Posted Date: 2010-06-22

Last Posted Date: 2018-08-21

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 218766

Registration Number: NCT01147328

Locations: 🇺🇸
HealtheLink, Buffalo, New York, United States
🇺🇸
Rochester RHIO, Rochester, New York, United States
🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLL

Phase 2

Completed

Conditions: Chronic Lymphocytic Leukemia

Interventions: Drug: thalidomide
Drug: lenalidomide
Biological: rituximab

First Posted Date: 2010-05-18

Last Posted Date: 2022-01-21

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 15

Registration Number: NCT01125176

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy